Biomarkers
/
Inflammation
/
Systemic Inflammation Response Index (SIRI)

Systemic Inflammation Response Index (SIRI)

The Systemic Inflammation Response Index (SIRI) = (neutrophils × monocytes) / lymphocytes, integrating innate inflammatory activity with adaptive immune regulation.
Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.
Book your test now
Book a Systemic Inflammation Response Index (SIRI) Test
With Superpower, you have access to a comprehensive range of biomarker tests
Physician reviewed
CLIA-certified labs
HIPAA compliant

Key benefits of Systemic Inflammation Response Index (SIRI) testing

  • Tracks your body's overall inflammatory burden using routine blood cell counts.
  • Flags chronic inflammation linked to cardiovascular disease and metabolic syndrome risk.
  • Helps explain persistent fatigue, joint pain, or unexplained symptoms tied to inflammation.
  • Guides lifestyle and treatment decisions to reduce long-term disease progression.
  • Monitors response to anti-inflammatory therapies or dietary interventions over time.
  • Supports cancer prognosis assessment when used alongside imaging and clinical staging.
  • Best interpreted with CRP, clinical symptoms, and other inflammatory markers for context.

What is Systemic Inflammation Response Index (SIRI)?

A calculated marker that captures immune system activation

The Systemic Inflammation Response Index (SIRI) is a composite biomarker calculated from three types of white blood cells: neutrophils, monocytes, and lymphocytes. It combines these immune cell counts into a single ratio that reflects the balance between pro-inflammatory and regulatory immune responses. Unlike measuring just one cell type, SIRI captures a broader picture of how your immune system is mobilizing.

What it reveals about your body's inflammatory state

SIRI reflects the intensity and character of systemic inflammation, the body-wide immune activation that occurs during infection, tissue injury, chronic disease, or stress. Neutrophils and monocytes rise when inflammation ramps up, while lymphocytes often drop during acute stress or illness.

The ratio amplifies these shifts, making SIRI sensitive to immune imbalance. Higher values suggest a more aggressive inflammatory response, which can accompany conditions ranging from acute infections to cancer and cardiovascular disease. It serves as a window into how hard your immune system is working and whether that response is proportionate or excessive.

Why is Systemic Inflammation Response Index (SIRI) important?

SIRI is a composite blood marker that captures the balance between immune activation and regulation by combining neutrophils, monocytes, and lymphocytes. It reflects how your body is managing inflammation across multiple systems, from blood vessels to metabolic organs. Values typically range from under 0.5 to above 3.0, with lower numbers indicating a calmer, more controlled immune state.

When inflammation stays quiet

Values below 0.5 suggest minimal systemic inflammation and a well-regulated immune response. This typically reflects good metabolic health, low oxidative stress, and efficient tissue repair. People in this range often experience stable energy, fewer infections, and lower cardiovascular strain.

When the immune system shifts into overdrive

Elevated SIRI, especially above 1.5 to 2.0, signals that neutrophils and monocytes are outpacing lymphocytes, a pattern seen in chronic inflammation, infection, or tissue injury. This imbalance can drive atherosclerosis, insulin resistance, and accelerated aging of organs. Symptoms may include fatigue, poor wound healing, or recurrent illness, though many people feel no immediate effects.

The long view on immune balance

SIRI connects inflammation to nearly every chronic disease, from heart disease and diabetes to cancer progression. It offers insight into how well your body manages stress, infection, and repair over time. Tracking this marker helps reveal whether silent inflammation is quietly shaping your long-term health trajectory.

What do my Systemic Inflammation Response Index (SIRI) results mean?

Low SIRI values

Low values usually reflect minimal systemic inflammation and a balanced immune response. SIRI combines neutrophils, monocytes, and lymphocytes in a way that captures the interplay between pro-inflammatory and regulatory immune cells. When SIRI is low, it suggests that inflammatory signaling is quiet and that lymphocyte populations, which help modulate and resolve inflammation, are relatively preserved. This pattern is typical in healthy individuals without active infection, autoimmune activity, or tissue injury.

Optimal SIRI values

Being in range suggests that your immune system is maintaining equilibrium between activation and regulation. SIRI does not have a single universal reference range, but lower values within the normal spectrum generally reflect better metabolic and cardiovascular health. Optimal SIRI tends to sit toward the lower end, indicating controlled inflammation and intact immune coordination.

High SIRI values

High values usually reflect systemic inflammation driven by an elevated neutrophil and monocyte response relative to lymphocytes. This pattern is seen in acute infections, chronic inflammatory conditions, metabolic stress, and malignancy. Elevated SIRI has been associated with worse outcomes in cardiovascular disease, cancer, and critical illness, as it signals ongoing immune activation and potential tissue damage.

Notes on interpretation

SIRI can be influenced by acute illness, surgery, trauma, chronic disease, and certain medications like corticosteroids. It is most informative when interpreted alongside clinical context and other inflammatory markers.

SIRI is calculated as (neutrophils × monocytes) ÷ lymphocytes. Higher values indicate stronger innate inflammatory drive relative to adaptive immunity, while lower values suggest more lymphocyte balance.
It is widely studied in cardiovascular disease, cancer, and chronic inflammation.

Do I need a Systemic Inflammation Response Index (SIRI) test?

Feeling constantly run down, struggling with unexplained aches, or noticing your body just isn't recovering like it used to? Could hidden inflammation be driving these symptoms?

SIRI measures your body's inflammatory response by combining key immune cell counts. It reveals whether chronic inflammation might be undermining your energy, recovery, and overall wellbeing.

Testing your SIRI gives you a powerful snapshot of what's happening beneath the surface, connecting the dots between those persistent symptoms and your body's inflammatory state. This clarity becomes your first step toward a personalized plan that addresses the root cause and helps you reclaim your vitality.

Get tested with Superpower

If you’ve been postponing blood testing for years or feel frustrated by doctor appointments and limited lab panels, you are not alone. Standard healthcare is often reactive, focusing on testing only after symptoms appear or leaving patients in the dark.

Superpower flips that approach. We give you full insight into your body with over 100 biomarkers, personalized action plans, long-term tracking, and answers to your questions, so you can stay ahead of any health issues.

With on-demand access to a care team, CLIA-certified labs, and the option for at-home blood draws, Superpower is designed for people who want clarity, convenience, and real accountability - all in one place.

Method: Derived from FDA-cleared laboratory results. This ratio/index is not an FDA-cleared test. It aids clinician-directed risk assessment and monitoring and is not a stand-alone diagnosis. Inputs: neutrophils, monocytes, lymphocytes.

Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.

Similar biomarker tests from Superpower

See more biomarkers

FAQs about Systemic Inflammation Response Index (SIRI)

Systemic Inflammation Response Index (SIRI) is a calculated biomarker derived from routine white blood cell counts - neutrophils, monocytes, and lymphocytes. It compresses these immune signals into a single ratio to reflect systemic (body-wide) inflammation and immune activation. Because it captures both pro-inflammatory cells (neutrophils, monocytes) and regulatory/adaptive activity (lymphocytes), SIRI can indicate whether inflammation is proportionate or excessive.

SIRI is computed using three white blood cell types commonly reported on a complete blood count (CBC) with differential: neutrophils, monocytes, and lymphocytes. The index combines these counts into a ratio designed to amplify the typical inflammation pattern - neutrophils and monocytes rising while lymphocytes fall under stress or illness. Your lab may calculate SIRI automatically, or a clinician can derive it from the CBC values.

Most reference discussions place an “optimal” SIRI below about 1.0 to 2.0, though cutoffs vary by population and clinical context. Values below 1.0 are often associated with well-regulated immune activity and minimal ongoing systemic inflammation. This pattern suggests white blood cells are in balanced proportion, supporting effective tissue repair and stable metabolic and cardiovascular function, especially in otherwise healthy adults without active infection or injury.

Elevated SIRI - often above 2.0 to 3.0 - typically reflects higher neutrophils and monocytes relative to lymphocytes, consistent with heightened systemic inflammation. This pattern can appear with severe infection, trauma, recent major surgery, autoimmune flares, advanced cancer, or cardiovascular events. Persistently high SIRI is linked in studies to worse outcomes in heart disease, stroke, malignancy, and metabolic syndrome due to ongoing inflammatory strain.

SIRI helps flag chronic, “silent” inflammation that can accelerate vascular aging, insulin resistance, frailty, and metabolic dysfunction. Because it integrates innate immune activation (neutrophils/monocytes) with adaptive regulation (lymphocytes), it offers a broader snapshot of inflammatory burden than a single cell count. Chronic elevation is associated with cardiovascular disease and metabolic syndrome risk, helping guide prevention strategies and track whether inflammation is improving over time.

Yes - SIRI can support the evaluation of ongoing, low-grade systemic inflammation that may contribute to persistent fatigue, joint pain, brain fog, or other unexplained symptoms. A higher SIRI suggests immune activation is elevated, which can impair energy production, recovery, and tissue repair. However, SIRI is not diagnostic on its own; it is best interpreted alongside symptoms, clinical history, and other inflammatory markers such as CRP for context.

SIRI reflects immune-cell balance using neutrophils, monocytes, and lymphocytes, while CRP (C-reactive protein) is a liver-produced inflammatory protein that often rises with acute inflammation. Using SIRI alongside CRP provides complementary insight: SIRI captures immune distribution and stress patterns, and CRP reflects systemic inflammatory signaling. Interpreting both together - plus symptoms and other markers - helps reduce misinterpretation from transient illness, stress, or medication effects.

SIRI can rise during acute infections, major surgery, trauma, cardiovascular events, and flares of autoimmune or inflammatory disease. These situations commonly increase neutrophils and monocytes while lowering lymphocytes, pushing the ratio upward. Because SIRI is sensitive to immune shifts, short-term elevations may reflect a temporary response rather than chronic disease. Trend tracking over time can help distinguish a transient spike from persistent inflammation.

Low SIRI generally suggests minimal systemic inflammation and a balanced immune response. Very low values are less common and may indicate immune suppression or inadequate white blood cell production in certain contexts. Potential contributors mentioned in clinical interpretation include bone marrow disorders, severe nutritional deficits (especially B12, folate, or protein), or medications that dampen immune function. Clinical correlation is important to rule out underlying causes.

SIRI can be trended over time to monitor whether systemic inflammation improves with anti-inflammatory therapies, lifestyle changes, or dietary interventions. Falling values may suggest better immune balance and reduced inflammatory burden, while persistent elevation can signal ongoing drivers such as metabolic syndrome or chronic disease activity. In oncology, SIRI may support prognosis assessment when used alongside imaging and clinical staging, rather than serving as a stand-alone cancer test.